Lung cancer molecular testing: what's next?
Pembrolizumab and epacadostat for NSCLC: ECHO-306/KEYNOTE-715
Nurses and the growth of personalized cancer care
How the AURA3 trial has changed conversations about re-biopsy in second-line lung cancer treatment
Biomarkers are revolutionizing the treatment landscape for NSCLC